Skip to main content
. 2021 Jan 29;3(1):vdab019. doi: 10.1093/noajnl/vdab019

Table 1.

Patient parameters and AR expression measured from tissue samples and SUVmean/max/Control values obtained from [18F]-FDHT PET/CT scans from the 12 patients included in this study. Pearson’s r correlation coefficients and P values are also presented

Patient Age Sex Pathology Location KPS AR protein tumor/ NB SUVmean/ Con SUVmax/ Con
1 79 M Glioblastoma, IDH Wild type Mid-frontal/corpus callosum 70 1.3 0.6 0.7
2 62 M Glioblastoma, IDH Wild type Right temporal 80 2.2 1.5 1.6
3 53 F Anaplastic Astrocytoma, IDH Mutant Bilateral gliomatosis 80 Un-available 0.96 0.91
4 63 M Glioblastoma, IDH Wild type Right temporal 80 1.9 1.5 1.7
5 31 F Glioblastoma, IDH Wild type Left occipito-parietal 90 2.3 2.5 3.4
6 54 M Glioblastoma, IDH Wild type Left frontal 80 2.8 2.6 2
7 69 F Glioblastoma, IDH Wild type Right temporo-parieto-occipital corpus callosum 80 1.9 1.6 1.7
8 39 M Oligodendroglioma, IDH Mutant Left frontal 80 1.1 0.6 1.0
9 72 F Anaplastic Astrocytoma, NOS Left frontal 80 3.1 1.8 2.1
10 86 F Glioblastoma, IDH Wild type Left parietal 80 1.5 1.3 1.3
11* 76 M Demyelination disease - 80 1.1 0.82 0.6
12 69 F Glioblastoma, IDH Wild type Left temporal 80 0.8 0.68 1.00
r score AR protein expression SUV/Con 0.84 0.67
Pvalue .002 .03

* non tumoral lesion; NB, normal brain.